Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Jing Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0958-5506; OpenAlex author ID A5100374964. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Targeted mitochondrial therapy for pancreatic cancer. Last author DOI 10.1016/j.tranon.2025.102340↗
  2. Immune-related genes LAMA2 and IL1R1 correlate with tumor sites and predict poor survival in pancreatic adenocarcinoma. Last author DOI 10.2217/fon-2020-1012↗
  3. IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer. Co-author DOI 10.7150/thno.42416↗
  4. MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1. Co-author DOI 10.1038/s41598-017-11248-3↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinya Zhao · 1 shared paper, 2025 · strength 0.33
  2. Xufeng Tao · 1 shared paper, 2025 · strength 0.33
  3. Deshi Dong · 1 shared paper, 2025 · strength 0.33
  4. Mengna Zhang · 1 shared paper, 2021 · strength 0.16
  5. Shengyu Yang · 1 shared paper, 2020 · strength 0.11
  6. Fanjie Jin · 1 shared paper, 2020 · strength 0.11
  7. Chongbiao Huang · 1 shared paper, 2020 · strength 0.11
  8. Xiuchao Wang · 1 shared paper, 2020 · strength 0.11
  9. Song Gao · 1 shared paper, 2020 · strength 0.11
  10. Tiansuo Zhao · 1 shared paper, 2020 · strength 0.11
  11. Jihui Hao · 1 shared paper, 2020 · strength 0.11
  12. Qiu Zhao · 1 shared paper, 2017 · strength 0.07
  13. Hongling Wang · 1 shared paper, 2017 · strength 0.07
  14. Rui Zhou · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.